Abstract
Introduction
Ž . All subclasses of granulocytes, i.e. neutrophils PMNL , eosinophils and basophils, have been reported as being present in arteriosclerotic arterial thickening in several w x models of experimental arteriosclerosis 1-4 , but their role in atherogenesis is less well understood. In a rabbit model of intimal thickening by electrical stimulation of carotid artery, PMNL are among the predominant types of leukocytes that migrate across an intact endothelium into w x the subendothelial space 5 . In experimental arteriosclerosis, blockade of leukocyte infiltration resulted in a 70% reduction of intimal smooth muscle cell accumulation w x 6 and invasion of the arterial intima by PMNL in this model was completely prevented by an antibody directed ) Ž .
Ž . Corresponding author. Tel.: q43 512 504-3255; Fax: q43 512 504-4201; E-mail: christian.wiedermann@uibk.ac.at Ž . toward the common b chain CD18 of the leukocyte 2 adherence complex CD11rCD18, whereas the influx of Ž . monocuclear leukocytes MNC was only partially inhibw x ited 6 . Under this condition, smooth muscle cell migration into the intima was not affected, thus excluding PMNL invasion as a prerequisite for the movement of w x smooth muscle cells into the intimal compartment 7 . Data suggest that MNC, but not PMNL, promote lesion develw x opment by stimulating smooth muscle cell migration 7 .
Oxidized low-density lipoprotein increases endothelial susceptibility to PMNL-induced endothelial dysfunction in w x porcine coronary arteries 8 . Additionally, it has been shown that atherosclerosis enhances the endothelial adhew x siveness for monocytes and lymphocytes 9,10 , which suggests that the interaction of intact endothelium with Time for primary review 21 days.
0008-6363r98r$19.00 q 1998 Elsevier Science B.V. All rights reserved. PMNL may lead to the release of secretory products which are chemotactic for monocytes and lymphocytes.
The purpose of the present in vitro study was to investigate the role of PMNL for monocyte recruitment in atherosclerosis upon interaction of PMNL with intact endothelium in the absence of additional inflammatory or infectious stimuli. The effects on the release of MNC chemoattractants by the interaction between PMNL and intact endothelial monolayers were tested. Our experiments suggest that the initial contact of PMNL with endothelial cells as it occurs in models of experimental arteriosclerosis, contributes to the recruitment of monocytes and lymphocytes by release of monocyte chemoattractant protein-1 Ž . MCP-1 . 
Methods

Reagents
Coculture of HUVEC with PMNL or MNC
HUVEC were grown to confluence in 24-well tissue culture plates or in Transwell filter insets before 600 or Ž
6
. 100 ml of PMNL suspensions 1.0 = 10 cellsrml ECGM were added to the monolayers and allowed to interact for Ž . various periods of time 0.5-5 h or monolayers remained untreated. In another set of experiments, HUVEC were Ž . preincubated for 30 min with cycloheximide 5 mgrml prior to washing with PBS and addition of PMNL with or Ž . without TNF-a 10 ngrml preincubation. Supernatants were collected, purified by centrifugation and subjected either to the Boyden microchemotaxis chamber assays or always to ELISA detection of MCP-1 contents. At least, HUVEC monolayers were examined microscopically and appeared to be unharmed.
MNC and monocyte chemotaxis assay
Chemotaxis through cellulose nitrate to gradients of w x soluble attractants was measured as described 12,15 using Ž a 48-well microchemotaxis chamber Neuroprobe, . Bethesda, MA, USA in which a 5-mm pore-sized cellu-Ž . lose nitrate filter Sartorius, Gottingen, Germany separates the upper and lower chambers, allowing only the actively migrating cells to get through the pores. MNC or purified Ž 4 . monocytes 5 = 10 cellsrwell in RPMI-1640r0.5% BSA were placed in the upper chamber and soluble attractants in the lower chamber. Attractants were either 10 nmolrl of fMLP as positive control or supernatants derived from treated or untreated HUVEC cultures. In some experi-Ž . ments, a purified anti-MCP-1 mAb 1.0 mgrml was added to the supernatants in the lower compartment. After 90 min at 378C, the nitrocellulose filters were dehydrated, fixed, and stained with hematoxylin-eosin as described w x 11 . Migration along the filter was quantified by microscopy, measuring the distance from the surface of the Ž . expressed as chemotaxis index CI , which is the ratio between the distance of migration towards the test attractants and the distance of migration towards control medium. The migration depth of the leading front in the medium controls was 50-75 mm.
ELISA for MCP-1
For direct measurement of MCP-1 contents in supernatants from cocultures of HUVEC and PMNL, a commer-Ž cially available sandwich ELISA kit R & D Systems Quan-. tikine human MCP-1, Minneapolis, MN, USA was performed in accordance with the manufacturer's instructions. This assay is stated to recognize both natural and rMCP-1, but exhibits no cross-reactivity with any other molecules tested, including IL-8, RANTES, IL-1b, serum amyloid protein, and epidermal growth factor.
Statistical analyses
All values are expressed as mean " s.e.m. Prior to two-group comparisons using the Mann-Whitney U-test, all data sets were analyzed for multigroup comparison by the Kruskal-Wallis analysis of variance. Probability values below 0.05 were considered to be statistically significant. For all statistical analyses, the StatView software package Ž . Abacus Concepts, Berkeley, CA, USA was used.
The investigation conforms to the principles outlined in the Declaration of Helsinki.
Results
InÕolÕement of MCP-1 in MNC chemotactic actiÕity of supernatants from cocultures of HUVEC and PMNL
MNC migration toward supernatant from cultures of HUVEC without PMNL remained almost unaffected, whereas addition of PMNL to HUVEC for 60 min produced supernatants which induced significant MNC migration. Supernatants harvested from HUVEC that were primed with TNF-a for 4 h and subsequently interacted with PMNL or medium for 60 min, stimulated MNC Ž . migration to an equal extent Fig. 1 .
In a following set of experiments, we tried to clarify a substrate for the chemotactic activity of the supernatants from PMNLrHUVEC-cocultures. Chemotactic activities of each supernatant could be significantly decreased by an Ž . anti-MCP-1 mAb 1 mgrml . Addition of the specific antibody to the supernatants from PMNL-incubated HU-VEC suppressed the chemotactic effect to random migra-Ž . tion levels Fig. 1, left , independent experiments ns6 . n.s., not significant; P -0.05; P -0.01.
. nmolrl served as positive control for migration of MNC. The anti-MCP-1 mAb itself affected neither random migra-Ž tion nor fMLP-stimulated migration of MNC data not . shown .
Dose dependency of chemotactic migration of purified human monocytes toward supernatants from cocultures of HUVEC and PMNL
To investigate whether chemotactic effects of the supernatants are dose-dependent, we performed a series of chemotaxis experiments in which we exposed purified Ž q . Ž monocytes CD14 to various dilutions 1:1, 1:10, 1:100, . 1:1000 of supernatants from HUVEC-PMNL cocultures. Results show that the more the supernatants were diluted, the less was the chemotactic response. Addition of an Ž . anti-MCP-1 mAb 1 mgrml to the various dilutions of supernatants was able to diminish the chemotactic re-Ž . sponse to baseline Table 1 .
Time-dependent release of MCP-1 from HUVEC into supernatants from HUVEC-PMNL cocultures and effects of cycloheximide
In order to investigate a possible time dependency of MCP-1 release from HUVEC-PMNL cocultures, time periods allowed for PMNL to interact with HUVEC monolayers were varied from 0.5 to 5 h. After these periods of coincubation, supernatants were assayed for immunoreactive MCP-1 as well as monocyte chemotactic activity. Fig.  2 shows that exposure of HUVEC to PMNL gives rise to rapid increase in secreted MCP-1, being significant after 60 min and increasing for up to 5 h, the longest time period tested. To examine whether de novo protein synthesis is involved in the observed MCP-1 release, we preincu-Ž . bated HUVEC monolayers with cycloheximide 5 mgrml for 30 min prior to interaction with PMNL. Pretreatment of HUVEC with cycloheximide led to a suppression in MCP-1 release over the whole period of time.
When supernatants were tested for chemotactic activity for purified human monocytes in the Boyden chamber assay, the migratory response was significantly increased at 60 min to 5 h. Pretreatment of HUVEC with cyclohex-Ž . Fig. 2 . Monocyte chemoattractant protein-1 MCP-1 levels and monocyte chemotactic activity of conditioned media of cocultures of neu-Ž . Ž . trophils PMNL and human umbilical vein endothelial cells HUVEC .
Ž . After pretreatment with or without cycloheximide 5 mgrml , confluent HUVEC monolayers were coincubated with PMNL for the indicated time periods and MCP-1 concentration was measured by ELISA or chemotactic activity was determined by the Boyden chamber micropore filter Ž . assay. Migration of monocytes toward f-Met-Leu-Phe 10 nmolrl Ž . revealed a chemotaxis index CI of 1.66"0.085. CI represents the ratio between the distance of monocyte migration toward chemoattractant and the distance of migration toward control medium. Values represent mean"s.e.m. for quadruplicate determinations in six independent experi-Ž . ments ns6 .
imide completely blunted the chemotactic action of the Ž . supernatants Fig. 2 . 
Discussion
In the pathophysiology of cardiovascular diseases, in which there is an accumulation of monocytes in the subendothelial space, an interaction between PMNL and EC is known to occur. Therefore, the question arises whether such interaction induces production of MNC chemoattractants. We attempted to answer this question by investigating in vitro the interaction between PMNL and HUVEC. Our experiments show that cocultures of resting PMNL and unstimulated or TNF-a-primed HUVEC monolayers induced an increase in the amounts of soluble MCP-1 secreted from EC. MCP-1 secreted into supernatants exhibited chemotactic activity for MNC and this effect was abolished in the presence of anti-MCP-1 mAb. Quantification of MCP-1 protein in medium indicates that augmented production of MCP-1 was induced by PMNL in HUVEC to levels comparable to MCP-1 released by TNF-a or w x direct cell-to-cell contact with monocytes 16 . These results indicate that during the process of adhesion, PMNL transmit signals to EC inducing MCP-1 synthesis and release.
Previous results suggested that the monocyte-EC adhesive interaction induces an MCP-1-inductive signal to each w x w x cell type 16 . Since PMNL fail to produce MCP-1 17 , the MCP-1 activity obtained in media of PMNL-exposed HUVEC can be assumed to originate exclusively from the HUVEC.
Although PMNL are capable of destroying tissue by w x secreting proteolytic enzymes 18 , they are rare in atherow x sclerotic lesions 19,20 . PMNL may occasionally be found in disrupted plaques beneath coronary thrombi, probably w x entering these plaques shortly after disruption 19 and may also migrate into the arterial wall shortly after reperfusion of occluded arteries in response to ischemiarreper- Since MNC comprise a mixture of monocytes and lymphocytes, monocytes were identified as a chemotactically responsive cell population by experiments using purified CD14 q cells. Time course experiments in adhesion assays confirm that the response occurs rapidly and induces chemokine release as early as 60 min and steadily Ž . increases for up to 5 h Fig. 2 . Similar kinetics have been previously reported, in particular when experiments were w x performed in combination with cytokines 16 . As the time course data were similar for MCP-1 protein and functional response of monocytes in the chemotaxis assay and both abrogated by pretreatment of HUVEC with cycloheximide, de novo synthesis of MCP-1 may be primarily responsible for the monocyte chemotactic activity. The time required for de novo synthesis of chemokines, lymphokines and cytokines in vitro, may be between 2 and 6 h; in some experimental systems, initial mediator release, however, w x may occur after 1 h 16,24,25 . Since levels of MCP-1 released from HUVEC by PMNL reached plateau after 4 h, whereas effects on monocyte chemotaxis increased continually over time, MCP-1 may not be the only monocytechemotactic factor released upon PMNL stimulation of Ž . HUVEC Fig. 2 .
The in vivo kinetics of PMNL transendothelial migration are unknown. We and others have previously shown in an in vitro system that PMNL in the subendothelial space can be seen as early as 30 min after PMNL are w x added to EC monolayers 14,22 . A previous study on MCP-1 induction by coculture of monocytes and EC suggested that the induction of MCP-1 mRNA occurs relaw x tively early, 2-4 h after coculture 16 . This rapidity may indicate that direct cell-cell contact rather than the presence of soluble factors such as IL-1 is required in the early phase of MCP-1 induction. We directly compared induction of MCP-1 synthesis by PMNL-HUVEC interaction with that by MNC-HUVEC interaction and observed comparable early responses, also suggesting that the endothelial MCP-1 production is directly induced by interaction Ž . with PMNL unpublished data .
The precise role of endothelial-PMNL interactions in atherogenesis and the development of vascular events is unknown. Interaction of PMNL with EC has previously been shown to result in the release of endothelium-derived w x growth factors 25 . PMNL-EC interactions may contribute to endothelial vasodilator dysfunction in atherosclerotic w x w x arteries 8 with inappropriate vasoconstriction 26 . The present study shows that PMNL induce EC to synthesize MCP-1 which may lead to monocyte accumulation in the vascular wall. Since MCP-1 may be especially important w x in the pathogenesis of atherosclerosis 27 , our results suggest a new pathogenetic link between PMNL and endothelial activation. MCP-1 has been demonstrated in w x macrophage-rich areas of atherosclerotic lesions 28 . In-Ž . cluded in the b C-C subfamily of chemokines, MCP-1 is a relatively specific chemoattractant for monocytes and is w x produced by a variety of cell types 29 . Stimuli for MCP-1 w x production include modified oxidized LDL 30 and cyw x tokines 29 . Cytokine production and cellular activation have been induced by direct cell-to-cell contact in a variety w x of cell types 31,32 .
In conclusion, our data indicate that EC are primed to produce MCP-1 through direct cellular contact with PMNL during adhesion even in the absence of additional stimulation by proinflammatory cytokines such as TNF-a. PMNL-induced production of MCP-1 by endothelium may be an important mechanism in the recruitment of blood monocytes to the vessel wall and thus in the pathogenesis of atherosclerosis. 
